
Sign up to save your podcasts
Or
Association Between Buprenorphine Treatment Gaps, Opioid Overdose, and Health Care Spending in US Medicare Beneficiaries With Opioid Use Disorder
JAMA Psychiatry
In this case-control study of 34,505 Medicare beneficiaries, patients had greater risk of experiencing an opioid overdose and higher health care expenditures in buprenorphine treatment gap months compared with treated months. Buprenorphine nonadherence is associated with an increased risk of opioid overdose and higher health care spending in Medicare.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
4.9
77 ratings
Association Between Buprenorphine Treatment Gaps, Opioid Overdose, and Health Care Spending in US Medicare Beneficiaries With Opioid Use Disorder
JAMA Psychiatry
In this case-control study of 34,505 Medicare beneficiaries, patients had greater risk of experiencing an opioid overdose and higher health care expenditures in buprenorphine treatment gap months compared with treated months. Buprenorphine nonadherence is associated with an increased risk of opioid overdose and higher health care spending in Medicare.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
129 Listeners
707 Listeners
281 Listeners
253 Listeners
3,336 Listeners
31 Listeners
1,324 Listeners
716 Listeners
290 Listeners
562 Listeners
122 Listeners
33 Listeners
175 Listeners
112 Listeners
17 Listeners